Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Jun 13;5(2):2055217319856903.
doi: 10.1177/2055217319856903. eCollection 2019 Apr-Jun.

No differential gene expression for CD4+ T cells of MS patients and healthy controls

Affiliations

No differential gene expression for CD4+ T cells of MS patients and healthy controls

Ina S Brorson et al. Mult Scler J Exp Transl Clin. .

Abstract

Background: Multiple sclerosis-associated genetic variants indicate that the adaptive immune system plays an important role in the risk of developing multiple sclerosis. It is currently not well understood how these multiple sclerosis-associated genetic variants contribute to multiple sclerosis risk. CD4+ T cells are suggested to be involved in multiple sclerosis disease processes.

Objective: We aim to identify CD4+ T cell differential gene expression between multiple sclerosis patients and healthy controls in order to understand better the role of these cells in multiple sclerosis.

Methods: We applied RNA sequencing on CD4+ T cells from multiple sclerosis patients and healthy controls.

Results: We did not identify significantly differentially expressed genes in CD4+ T cells from multiple sclerosis patients. Furthermore, pathway analyses did not identify enrichment for specific pathways in multiple sclerosis. When we investigated genes near multiple sclerosis-associated genetic variants, we did not observe significant enrichment of differentially expressed genes.

Conclusion: We conclude that CD4+ T cells from multiple sclerosis patients do not show significant differential gene expression. Therefore, gene expression studies of all circulating CD4+ T cells may not result in viable biomarkers. Gene expression studies of more specific subsets of CD4+ T cells remain justified to understand better which CD4+ T cell subsets contribute to multiple sclerosis pathology.

Keywords: CD4+ T cells; Genetics; RNA sequencing; gene expression; multiple sclerosis.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Boxplots of the five most consistently differentially expressed genes in CD4+ T cells from multiple sclerosis (MS) patients compared to healthy controls (HC). (a) RPL21P16; (b) RBM27; (c) CAMK4; (d) LIMK2; (e) CLUAP1. Individual expression levels are presented for healthy controls (square dots) and MS patients (triangular dots). The boxes delimit 25% and 75% of the values; the horizontal bars represent the median value. The whiskers represent values that do not exceed a distance of 1.5 times the interquartile range from the middle 50% of the data.

Similar articles

Cited by

References

    1. Olsson T, Barcellos LF, Alfredsson L. Interactions between genetic, lifestyle and environmental risk factors for multiple sclerosis. Nat Rev Neurol 2017; 13: 25–36. - PubMed
    1. The International Multiple Sclerosis Genetics Consortium (IMSGC). The Multiple Sclerosis Genomic Map: role of peripheral immune cells and resident microglia in susceptibility. BioRxiv 2017. DOI: 10.1101/143933. - PMC - PubMed
    1. Chitnis T. The role of CD4 T cells in the pathogenesis of multiple sclerosis. Int Rev Neurobiol 2007; 79: 43–72. - PMC - PubMed
    1. Huseby ES, Huseby PG, Shah S, et al. Pathogenic CD8 T cells in multiple sclerosis and its experimental models. Front Immunol 2012; 3: 64. - PMC - PubMed
    1. Dendrou CA, Fugger L, Friese MA. Immunopathology of multiple sclerosis. Nat Rev Immunol 2015; 15: 545–558. - PubMed